The first successful phase III trial of a possible COVID-19 vaccine – BNT162b2 – has been announced by drug companies Pfizer and BioNTech, which is able to prevent 90% of infections.
from Future Timeline | Latest Updates | Technology | Singularity | 2020 | 2050 | 2100 | 2150 | 2200 | 2.. https://ift.tt/2IqfdKu
via Digital Media
No comments:
Post a Comment